1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Hongchang Guo: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery Dapagliflozin 10 MG, Placebos - Diabetes Mellitus, Type 2, Cardiac Surgery | Phase 4 | Unknown | Hongchang Guo | 500 | 2021-01-01 | 2021-10-07 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
dapagliflozin (1)
China (1)